According to the American Cancer Society, pancreatic cancer will kill over 50,000 people in the U.S. this year. Although pancreatic cancer only accounts for 8 percent of all cancer deaths, the global death rate for this type of cancer is expected to double over the next 40 years. These troubling statistics are underscored by the fact that pancreatic cancer is a challenging case in cancer medicine because of its difficult diagnosis and lack of effective treatment options.
A new study, published in Gut Pathogens, suggests that the latest breakthrough in early cancer detection and treatment may have been inside us all along: our gut microbiome.
An international team of researchers has discovered that the bacteria that appear, or disappear, from our gut microbiome may hold the key to improving diagnosis rates for one of the deadliest types of cancer and could even be used to develop new treatments.
Read More: ...
